Back to Directory
PNC-27
Performance & EnduranceExperimental anti-cancer peptide that targets cancer cells while sparing normal cells.
Key Benefits
- ✓Selective cancer cell targeting
- ✓Induces cancer cell death
- ✓Spares normal cells
- ✓Research for multiple cancer types
Dosing Information
Dosage Range
Research only
Frequency
Research only
Typical Duration
Research only
Detailed Protocol
Research compound only. Not approved for human use. Various administration routes being studied including IV and direct injection.
About PNC-27
PNC-27 is a synthetic peptide consisting of an HDM-2-binding domain linked to a membrane penetration sequence. It is designed to induce necrosis specifically in cancer cells while leaving normal cells unharmed. Experimental research use only.
Research Notes
Preclinical research shows selective cytotoxicity to cancer cells. Multiple cancer types being studied. Not approved for clinical use.
Potential Side Effects
- •Research compound
- •Not approved for human use
- •Safety profile not established
Always consult with a healthcare professional before starting any peptide therapy.